TrueMark Investments’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $381K | Sell |
111,119
-4,272
| -4% | -$14.7K | 0.08% | 131 |
|
|
2025
Q1 | $257K | Sell |
115,391
-8,698
| -7% | -$19.4K | 0.07% | 140 |
|
|
2024
Q4 | $364K | Sell |
124,089
-10,325
| -8% | -$30.3K | 0.12% | 117 |
|
|
2024
Q3 | $349K | Buy |
134,414
+24,457
| +22% | +$63.6K | 0.11% | 155 |
|
|
2024
Q2 | $325K | Hold |
109,957
| – | – | 0.11% | 157 |
|
|
2024
Q1 | $498K | Buy |
109,957
+13,104
| +14% | +$59.4K | 0.46% | 50 |
|
|
2023
Q4 | $553K | Buy |
+96,853
| New | +$553K | 0.55% | 50 |
|